usbancorp cap - ASRV
ASRV
Close Chg Chg %
3.78 -0.04 -1.06%
Closed Market
3.74
-0.04 (1.06%)
Volume: 8.73K
Last Updated:
Jun 5, 2026, 4:00 PM EDT
Company Overview: usbancorp cap - ASRV
ASRV Key Data
| Open $3.77 | Day Range 3.68 - 3.77 |
| 52 Week Range 2.64 - 4.04 | Market Cap $64.13M |
| Shares Outstanding 16.96M | Public Float 12.49M |
| Beta 0.43 | Rev. Per Employee N/A |
| P/E Ratio 11.45 | EPS $0.33 |
| Yield 317.46% | Dividend $0.03 |
| EX-DIVIDEND DATE May 4, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 10.91K |
ASRV Performance
| 1 Week | 2.16% | ||
| 1 Month | 3.56% | ||
| 3 Months | 1.07% | ||
| 1 Year | 26.42% | ||
| 5 Years | -8.92% |
ASRV Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
1
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
SEC Filings for Usbancorp Cap - ASRV
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Usbancorp Cap - ASRV
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 7, 2026 | Jeffrey A. Stopko President & CEO ASRV & Bank | 169,379 | Open market or private purchase of non-derivative security Non-derivative transaction at $3.85 per share | 652,109.15 |
| Feb 26, 2026 | Kim W. Kunkle Director | 179,627 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $3.84 per share | 689,767.68 |
| Feb 26, 2026 | Kim W. Kunkle Director | 179,937 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $3.84 per share | 690,958.08 |
| Feb 26, 2026 | Kim W. Kunkle Director | 180,007 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $3.84 per share | 691,226.88 |
| Feb 26, 2026 | Daniel A. Onorato Director | 57,650 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $3.84 per share | 221,376.00 |
| Nov 25, 2025 | David J. Hickton Director | 25,964 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $3.28 per share | 85,161.92 |
| Aug 19, 2025 | Michael D. Lynch EVP/CFO | 17,892 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $2.43 per share | 43,477.56 |
| Aug 1, 2025 | Michael D. Lynch EVP/CFO | 17,832 | Open market or private purchase of non-derivative security Non-derivative transaction at $2.87 per share | 51,177.84 |
| Jun 12, 2025 | Mark E. Pasquerilla Director | 103,459 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $2.83 per share | 292,788.97 |
| Jun 12, 2025 | J. Michael Adams Director | 148,799 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $2.83 per share | 421,101.17 |
| Jun 12, 2025 | Amy Bradley Director | 34,413 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $2.83 per share | 97,388.79 |
| Jun 12, 2025 | Richard W. Bloomingdale Director | 31,129 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $2.83 per share | 88,095.07 |